XENON PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
XENON PHARMACEUTICALS INC. (XENE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 149.98 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 92.87K shares, a 44.82% decline year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 57.11K shares, a 74.74% decline year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 48.09K shares, a 51.78% decline year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 284.66K shares, a 391.41% increase year-over-year.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 727.08K shares, a 249.73% increase from fiscal 2024.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 207.90K shares, a 16.65% increase from fiscal 2023.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 178.22K shares, a 221.87% increase from fiscal 2022.
- XENON PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 55.37K shares, a 73.11% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 92.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 149.98K shares 10-Q · filed 2026-08-06 | 198.07K shares derived: sum of 3 quarters · filed 2026-08-06 | 482.72K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 57.11K shares 10-Q · filed 2026-05-07 | 105.19K shares derived: sum of 2 quarters · filed 2026-05-07 | 389.85K shares derived: sum of 3 quarters · filed 2026-05-07 | 558.15K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 48.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 332.74K shares derived: sum of 2 quarters · filed 2026-02-26 | 501.04K shares derived: sum of 3 quarters · filed 2026-08-06 | 727.08K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 284.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 452.96K shares derived: sum of 2 quarters · filed 2026-08-06 | 678.99K shares 10-Q · filed 2025-11-03 | 778.71K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 168.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 394.34K shares 10-Q · filed 2026-08-06 | 494.05K shares derived: sum of 3 quarters · filed 2026-08-06 | 551.98K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 226.03K shares 10-Q · filed 2026-05-07 | 325.75K shares derived: sum of 2 quarters · filed 2026-05-07 | 383.68K shares derived: sum of 3 quarters · filed 2026-05-07 | 415.02K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 99.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 157.64K shares derived: sum of 2 quarters · filed 2026-02-26 | 188.99K shares derived: sum of 3 quarters · filed 2026-02-26 | 207.90K shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 57.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 89.27K shares derived: sum of 2 quarters · filed 2025-11-03 | 108.18K shares 10-Q · filed 2025-11-03 | 115.78K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 31.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 50.25K shares 10-Q · filed 2025-08-11 | 57.85K shares derived: sum of 3 quarters · filed 2026-02-26 | 90.27K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 18.91K shares 10-Q · filed 2025-05-12 | 26.51K shares derived: sum of 2 quarters · filed 2026-02-26 | 58.93K shares derived: sum of 3 quarters · filed 2026-02-26 | 123.73K shares derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 7.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 40.02K shares derived: sum of 2 quarters · filed 2026-02-26 | 104.82K shares derived: sum of 3 quarters · filed 2026-02-26 | 178.22K shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 32.42K shares 10-Q · filed 2023-11-08 | 97.22K shares derived: sum of 2 quarters · filed 2023-11-08 | 170.62K shares 10-Q · filed 2024-11-12 | 172.15K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 64.80K shares 10-Q · filed 2023-08-09 | 138.20K shares 10-Q · filed 2024-08-08 | 139.74K shares derived: sum of 3 quarters · filed 2025-02-27 | 161.09K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 73.40K shares 10-Q · filed 2024-05-09 | 74.93K shares derived: sum of 2 quarters · filed 2025-02-27 | 96.29K shares derived: sum of 3 quarters · filed 2025-02-27 | 124.87K shares derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 1.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 22.89K shares derived: sum of 2 quarters · filed 2025-02-27 | 51.47K shares derived: sum of 3 quarters · filed 2025-02-27 | 55.37K shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 21.36K shares 10-Q · filed 2023-11-08 | 49.94K shares derived: sum of 2 quarters · filed 2023-11-08 | 53.84K shares 10-Q · filed 2023-11-08 | 76.26K shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 28.58K shares 10-Q · filed 2023-08-09 | 32.48K shares 10-Q · filed 2023-08-09 | 54.91K shares derived: sum of 3 quarters · filed 2024-02-29 | 100.75K shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 3.90K shares 10-Q · filed 2023-05-09 | 26.32K shares derived: sum of 2 quarters · filed 2024-02-29 | 72.17K shares derived: sum of 3 quarters · filed 2024-02-29 | 203.89K shares derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 22.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 68.27K shares derived: sum of 2 quarters · filed 2024-02-29 | 200.00K shares derived: sum of 3 quarters · filed 2024-02-29 | 205.93K shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 45.84K shares 10-Q · filed 2022-11-08 | 177.57K shares derived: sum of 2 quarters · filed 2022-11-08 | 183.50K shares 10-Q · filed 2022-11-08 | 234.41K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | 131.73K shares 10-Q · filed 2022-08-09 | 137.66K shares 10-Q · filed 2022-08-09 | 188.56K shares derived: sum of 3 quarters · filed 2023-03-01 | 191.93K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | 5.94K shares 10-Q · filed 2022-05-10 | 56.84K shares derived: sum of 2 quarters · filed 2023-03-01 | 60.20K shares derived: sum of 3 quarters · filed 2023-03-01 | 65.34K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | 50.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 54.27K shares derived: sum of 2 quarters · filed 2023-03-01 | 59.41K shares derived: sum of 3 quarters · filed 2023-03-01 | 85.68K shares 10-K · filed 2023-03-01 |
| 2020-09-30 | 3.36K shares 10-Q · filed 2021-11-10 | 8.51K shares derived: sum of 2 quarters · filed 2021-11-10 | 34.77K shares 10-Q · filed 2021-11-10 | 84.61K shares derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 5.14K shares 10-Q · filed 2021-08-11 | 31.41K shares 10-Q · filed 2021-08-11 | 81.25K shares derived: sum of 3 quarters · filed 2021-08-11 | 124.34K shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | 26.27K shares 10-Q · filed 2021-05-11 | 76.11K shares derived: sum of 2 quarters · filed 2021-05-11 | 119.20K shares derived: sum of 3 quarters · filed 2021-05-11 | 119.40K shares derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | 49.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 92.93K shares derived: sum of 2 quarters · filed 2021-03-01 | 93.13K shares derived: sum of 3 quarters · filed 2021-03-01 | 97.09K shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 43.10K shares 10-Q · filed 2020-11-05 | 43.30K shares derived: sum of 2 quarters · filed 2020-11-05 | 47.25K shares 10-Q · filed 2020-11-05 | 52.44K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | 200.00 shares 10-Q · filed 2020-08-06 | 4.16K shares 10-Q · filed 2020-08-06 | 9.35K shares derived: sum of 3 quarters · filed 2020-08-06 | 51.94K shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | 3.96K shares 10-Q/A · filed 2020-05-26 | 9.15K shares derived: sum of 2 quarters · filed 2020-05-26 | 51.74K shares derived: sum of 3 quarters · filed 2020-05-26 | 104.39K shares derived: sum of 4 quarters · filed 2020-05-26 |
| 2018-12-31 | 5.19K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 47.78K shares derived: sum of 2 quarters · filed 2020-03-09 | 100.44K shares derived: sum of 3 quarters · filed 2020-03-09 | 123.44K shares 10-K · filed 2020-03-09 |
| 2018-09-30 | 42.59K shares 10-Q · filed 2019-11-05 | 95.25K shares derived: sum of 2 quarters · filed 2019-11-05 | 118.24K shares 10-Q · filed 2019-11-05 | 159.12K shares derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | 52.66K shares 10-Q · filed 2019-08-06 | 75.65K shares 10-Q · filed 2019-08-06 | 116.53K shares derived: sum of 3 quarters · filed 2019-08-06 | 187.09K shares derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | 23.00K shares 10-Q · filed 2019-05-07 | 63.87K shares derived: sum of 2 quarters · filed 2019-05-07 | 134.44K shares derived: sum of 3 quarters · filed 2019-05-07 | 142.44K shares derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | 40.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 111.44K shares derived: sum of 2 quarters · filed 2019-03-06 | 119.45K shares derived: sum of 3 quarters · filed 2019-03-06 | 120.86K shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 70.57K shares 10-Q · filed 2018-11-06 | 78.57K shares derived: sum of 2 quarters · filed 2018-11-06 | 79.99K shares 10-Q · filed 2018-11-06 | 81.72K shares derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | 8.01K shares 10-Q · filed 2018-08-07 | 9.42K shares 10-Q · filed 2018-08-07 | 11.15K shares derived: sum of 3 quarters · filed 2018-08-07 | 15.90K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | 1.42K shares 10-Q · filed 2018-05-08 | 3.14K shares derived: sum of 2 quarters · filed 2018-05-08 | 7.90K shares derived: sum of 3 quarters · filed 2018-05-08 | 10.12K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | 1.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 6.48K shares derived: sum of 2 quarters · filed 2018-03-07 | 8.71K shares derived: sum of 3 quarters · filed 2018-03-07 | 13.15K shares 10-K · filed 2018-03-07 |
| 2016-09-30 | 4.75K shares 10-Q · filed 2017-11-07 | 6.98K shares derived: sum of 2 quarters · filed 2017-11-07 | 11.42K shares 10-Q · filed 2017-11-07 | 11.47K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 2.23K shares 10-Q · filed 2017-08-03 | 6.67K shares 10-Q · filed 2017-08-03 | 6.72K shares derived: sum of 3 quarters · filed 2018-03-07 | 8.62K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 4.44K shares 10-Q · filed 2017-05-09 | 4.49K shares derived: sum of 2 quarters · filed 2018-03-07 | 6.39K shares derived: sum of 3 quarters · filed 2018-03-07 | 25.13K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 48.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 1.95K shares derived: sum of 2 quarters · filed 2018-03-07 | 20.69K shares derived: sum of 3 quarters · filed 2018-03-07 | 21.78K shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 1.91K shares 10-Q · filed 2016-11-03 | 20.64K shares derived: sum of 2 quarters · filed 2016-11-03 | 21.73K shares 10-Q · filed 2016-11-03 | 22.14K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-06-30 | 18.74K shares 10-Q · filed 2016-08-03 | 19.83K shares 10-Q · filed 2016-08-03 | 20.23K shares derived: sum of 3 quarters · filed 2017-03-08 | 24.64K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2015-03-31 | 1.09K shares 10-Q · filed 2016-05-10 | 1.50K shares derived: sum of 2 quarters · filed 2017-03-08 | 5.91K shares derived: sum of 3 quarters · filed 2017-03-08 | 8.49K shares derived: sum of 4 quarters · filed 2017-03-08 |
| 2014-12-31 | 406.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | 4.82K shares derived: sum of 2 quarters · filed 2017-03-08 | 7.40K shares derived: sum of 3 quarters · filed 2017-03-08 | 51.63K shares 10-K · filed 2017-03-08 |
| 2014-09-30 | 4.41K shares 10-Q · filed 2015-11-10 | 6.99K shares derived: sum of 2 quarters · filed 2015-11-10 | 51.23K shares 10-Q · filed 2015-11-10 | 56.99K shares derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | 2.58K shares 10-Q · filed 2015-08-13 | 46.82K shares 10-Q · filed 2015-08-13 | 52.58K shares derived: sum of 3 quarters · filed 2016-03-08 | 53.45K shares derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | 44.24K shares 10-Q/A · filed 2015-08-13 | 50.00K shares derived: sum of 2 quarters · filed 2016-03-08 | 50.87K shares derived: sum of 3 quarters · filed 2016-03-08 | |
| 2013-12-31 | 5.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | 6.63K shares derived: sum of 2 quarters · filed 2016-03-08 | 79.43K shares 10-K · filed 2016-03-08 | |
| 2013-09-30 | 876.00 shares 10-Q · filed 2014-12-15 | 73.67K shares 10-Q · filed 2014-12-15 | ||
| 2012-12-31 | 81.17K shares 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |